Updated:
Tandem Diabetes Care Inc.
Tandem Diabetes Care Inc.: TNDM on Nasdaq; SEC-reported financials and filings, CIK 0001438133.
Overview
Tandem Diabetes Care develops insulin pumps and other products and services for diabetes management. Its TNDM shares are listed on Nasdaq. Its principal executive office is in San Diego, CA, United States. For the fiscal year ended 2025-12-31, its originally filed 10-K reports revenue of USD 1,014,736,000; net income of USD -204,710,000; operating cash flow of USD -9,721,000. The filing date is 2026-02-19. At that year-end, its balance sheet reports total assets of USD 881,112,000 and cash and cash equivalents of USD 90,634,000. For the earlier fiscal year ended 2024-12-31, the originally reported figures include revenue of USD 940,203,000; net income of USD -96,025,000; operating cash flow of USD 24,225,000; year-end total assets of USD 967,658,000; year-end cash and cash equivalents of USD 69,234,000.
Company overview
- Legal name
- TANDEM DIABETES CARE INC
- Classification
- Public company
- Industry (SIC)
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: TNDM
- SEC CIK
- 0001438133
- Website
- tandemdiabetes.com
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $1.0B | -$204.7M | $881.1M | $90.6M | -$9.7M | |
| FY2024USD | $940.2M | -$96.0M | $967.7M | $69.2M | $24.2M | |
| FY2023USD | $747.7M | -$222.6M | $952.7M | $58.9M | -$31.8M | |
| FY2022USD | $801.2M | -$94.6M | $1.1B | $172.5M | $50.5M |
FY2025. Net income: shown as originally filed; later filings report different values for the same periods.
FY2024. Net income: shown as originally filed; later filings report different values for the same periods.
FY2023. Net income: shown as originally filed; later filings report different values for the same periods.
FY2022. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Tandem Diabetes Care Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.